United States · FDA National Drug Code directory

Naproxen

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71335-0095_59c90ed3-0908-4977-bb00-7f102e6d7aff
Product NDC
71335-0095
Form
TABLET
Composition / generic term
Naproxen
Labeler
Bryant Ranch Prepack
Marketing category
ANDA
Marketing start / end (source format)
20070701
Source listing expiry
20271231

Source-listed ingredients

  • NAPROXEN — 375 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 20 TABLET in 1 BOTTLE (71335-0095-1) · 71335-0095-1
  • 30 TABLET in 1 BOTTLE (71335-0095-2) · 71335-0095-2
  • 40 TABLET in 1 BOTTLE (71335-0095-3) · 71335-0095-3
  • 120 TABLET in 1 BOTTLE (71335-0095-4) · 71335-0095-4
  • 60 TABLET in 1 BOTTLE (71335-0095-5) · 71335-0095-5
  • 90 TABLET in 1 BOTTLE (71335-0095-6) · 71335-0095-6
  • 14 TABLET in 1 BOTTLE (71335-0095-7) · 71335-0095-7
  • 15 TABLET in 1 BOTTLE (71335-0095-8) · 71335-0095-8
  • 21 TABLET in 1 BOTTLE (71335-0095-9) · 71335-0095-9

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →